Eli Lilly Corp. buy Guggenheim
Start price
16.08.24
/
50%
€844.20
Target price
16.08.25
€935.65
Performance (%)
-28.93%
End price
17.08.25
€600.00
Summary
This prediction ended on 17.08.25 with a price of €600.00. The price of Eli Lilly Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.93%. Guggenheim has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €2.66 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | 3.243% | 3.243% | -14.096% |
| iShares Core DAX® | 1.008% | 1.922% | 24.056% |
| iShares Nasdaq 100 | 2.477% | 4.117% | 15.967% |
| iShares Nikkei 225® | 2.095% | 8.417% | 20.754% |
| iShares S&P 500 | 2.246% | 2.964% | 9.671% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Guggenheim from $884.00 to $1,030.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Eli Lilly Corp.
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-6.30%
06.08.25
06.08.25
